We are live on ! Find out more
MYOK

MyoKardia, Inc. Common Stock
MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

178 hedge funds and large institutions have $3.62B invested in MyoKardia, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 53 increasing their positions, 54 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 14

42% more capital invested

Capital invested by funds: $2.55B → $3.62B (+$1.07B)

13% more funds holding

Funds holding: 157178 (+21)

13% more funds holding in top 10

Funds holding in top 10: 89 (+1)

2% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 54

39% less call options, than puts

Call options by funds: $15.8M | Put options by funds: $26M

Holders
178
Holders Change
+21
Holders Change %
+13.38%
% of All Funds
3.51%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.18%
New
40
Increased
53
Reduced
54
Closed
14
Calls
$15.8M
Puts
$26M
Net Calls
-$10.3M
Net Calls Change
-$9.14M
Name Holding Trade Value Shares
Change
Change in
Stake
Ameriprise
101
Ameriprise
Minnesota
$1.39M +$95.8K +1,580 +9%
State Board of Administration of Florida Retirement System
102
State Board of Administration of Florida Retirement System
Florida
$1.34M +$7.88K +130 +0.7%
UONDDL
103
University of Notre Dame du Lac
Indiana
$1.33M +$1.11M +18,263 New
ProShare Advisors
104
ProShare Advisors
Maryland
$1.17M -$92.4K -1,524 -9%
TRSOTSOK
105
Teachers Retirement System of the State of Kentucky
Kentucky
$1.13M +$939K +15,486 New
Alkeon Capital Management
106
Alkeon Capital Management
New York
$1.09M +$910K +15,000 New
Citigroup
107
Citigroup
New York
$1.06M +$278K +4,575 +46%
MLICM
108
Metropolitan Life Insurance Company (MetLife)
New York
$1.04M -$15.4K -254 -2%
AC
109
Amia Capital
United Kingdom
$992K +$826K +13,616 New
SEI Investments
110
SEI Investments
Pennsylvania
$936K +$447K +7,365 +134%
LCM
111
Laurion Capital Management
New York
$926K +$770K +12,700 New
EAM
112
Erste Asset Management
Austria
$867K
EVM
113
Eaton Vance Management
Massachusetts
$847K
CIP
114
Chartwell Investment Partners
Pennsylvania
$839K +$699K +11,516 New
ACM
115
AlphaCrest Capital Management
New York
$838K -$255K -4,200 -27%
Principal Financial Group
116
Principal Financial Group
Iowa
$814K -$13.7K -226 -2%
CSS
117
Cubist Systematic Strategies
Connecticut
$772K +$46.7K +770 +8%
RJA
118
Raymond James & Associates
Florida
$758K +$109K +1,794 +21%
CA
119
CHI Advisors
New York
$729K -$756K -12,464 -55%
WMSA
120
Weiss Multi-Strategy Advisers
New York
$729K
TI
121
Trexquant Investment
Connecticut
$676K -$200K -3,298 -26%
Royal Bank of Canada
122
Royal Bank of Canada
Ontario, Canada
$637K +$128K +2,116 +32%
AB
123
Amalgamated Bank
New York
$595K +$18.8K +310 +4%
Allianz Asset Management
124
Allianz Asset Management
Germany
$582K -$6.92K -114 -1%
AI
125
Atom Investors
Texas
$556K -$10.9K -179 -2%

MYOK Hedge Fund Activity: Q4 2019 in Review

178 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q4 2019, worth a combined $3.62B — up 42% from $2.55B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new MYOK positions and 14 closed out — a net gain of 26 holders — while 53 added to existing stakes and 54 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $62.1M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $64M sold.

  • 178 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q4 2019, up from 157 in Q3 2019.
  • Funds reported $3.62B of MyoKardia, Inc. Common Stock stock for Q4 2019, up 42% quarter-over-quarter.
  • 40 funds opened new MyoKardia, Inc. Common Stock positions in Q4 2019 and 14 closed out, a net change of +26 holders.
  • The largest MyoKardia, Inc. Common Stock buyer in Q4 2019 was Janus Henderson Group, an estimated $62.1M added.
  • The largest MyoKardia, Inc. Common Stock seller in Q4 2019 was PFM Health Sciences, an estimated $64M sold.

Based on aggregated 13F filings for Q4 2019.